Mebias Discovery
Mebias Discovery is a Healthcare & Life Sciences startup based in the United States, most recent round Seed, 1 tracked investor.
About Mebias Discovery
Mebias Discovery is a company headquartered in the United States. Its most recent tracked round is Seed. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Mebias Discovery uses a proprietary membrane protein-NMR platform to identify molecules binding to G-protein coupled receptor (GPCR) targets, aiming to develop novel drugs with improved safety profiles. The company advances its own drug candidates into early clinical development, including Phase 1 trials for a mu-opioid receptor drug and sphingosine 1-phosphate receptor agonists addressing neuropathic pain and neuroinflammation.
Explore Mebias Discovery's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.